Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-021532
Filing Date
2015-03-03
Accepted
2015-03-03 17:27:43
Documents
1
Period of Report
2015-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7896
  Complete submission text file 0001209191-15-021532.txt   9265
Mailing Address 9050 CAMINO SANTA FE SAN DIEGO CA 92121
Business Address
XANTHOPOULOS KLEANTHIS G (Reporting) CIK: 0001283304 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 15670541

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations